Kondo T, Yoshida K, Tanayama S
Drug Analysis and Pharmacokinetics Research Laboratories, Takeda Chemical Industries Ltd., Osaka, Japan.
Biol Mass Spectrom. 1994 Jun;23(6):323-9. doi: 10.1002/bms.1200230605.
Combined liquid chromatography/thermospray mass spectrometry (full scan) and its tandem mass spectrometry (precursor ion, product ion and neutral loss scan) were used to characterize rat and dog plasma metabolites of an anxiolytic candidate (DN-2327; (+-)-2-(7-chloro-1,8-naphthyridin-2-yl)-3-[(1,4-dioxa-8- azaspiro[4.5]dec-8-yl)carbonylmethyl]isoindolin-1-one) . The results indicated that DN-2327 was metabolized to M-I by hydrolysis of the dioxolane ring which was subsequently reduced at the carbonyl moiety to form M-II. M-II was further metabolized to diol isomers, M-III and M-IV, by hydroxylation on the hydroxypiperidine moiety. M-V was an acyclic diol resulting from cleavage of the piperidine ring followed by reduction of the aldehyde. By the methodology used here, detailed structural information could be obtained without recourse to individual metabolite isolation and this provided a great saving in time and effort.
采用液相色谱/热喷雾质谱联用(全扫描)及其串联质谱(前体离子、产物离子和中性丢失扫描)对一种抗焦虑候选药物(DN - 2327;(±)-2-(7 - 氯 - 1,8 - 萘啶 - 2 - 基)-3 - [(1,4 - 二氧杂 - 8 - 氮杂螺[4.5]癸 - 8 - 基)羰基甲基]异吲哚 - 1 - 酮)在大鼠和犬血浆中的代谢产物进行表征。结果表明,DN - 2327通过二氧戊环环的水解代谢为M - I,随后羰基部分被还原形成M - II。M - II通过羟基哌啶部分的羟基化进一步代谢为二醇异构体M - III和M - IV。M - V是哌啶环断裂后醛基还原产生的无环二醇。通过此处使用的方法,无需分离单个代谢产物即可获得详细的结构信息,这大大节省了时间和精力。